Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Power Construction Group is a large-scale state-owned engineering and construction enterprise headquartered in Xi'an, China. As a key subsidiary of the Power Construction Corporation of China (PowerChina), the group specializes in the design, construction, and operation of power infrastructure, including thermal, hydroelectric, and renewable energy facilities. The company maintains a significant presence in the healthcare sector through its majority ownership of Xi'an Huitian Blood Products, a biopharmaceutical manufacturer focused on plasma-based therapies such as human albumin and immunoglobulin. Additionally, the group leverages its civil engineering expertise to provide general contracting services for the construction of hospitals and medical facilities globally. Through these activities, Shaanxi Power Construction Group integrates industrial infrastructure development with critical support for the life sciences and healthcare industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Power Construction Group.